Samsung Electronics has announced the expansion of its Samsung Health Monitor app, aimed at providing Galaxy Watch users with deeper insights into their heart health. The app’s new feature, the Irregular Heart Rhythm Notification (IHRN), allows users to track abnormal heart rhythms and gain a comprehensive understanding of their cardiovascular well-being.
Following recent approvals by the Korean Ministry of Food and Drug Safety (MFDS) and the U.S. Food and Drug Administration (FDA), the IHRN feature will soon be available in 13 markets worldwide. These markets include Argentina, Azerbaijan, Costa Rica, Dominican Republic, Ecuador, Georgia, Guatemala, Hong Kong, Indonesia, Panama, UAE, as well as Korea and the U.S.
The IHRN feature, combined with the app’s existing Electrocardiogram (ECG) monitoring functionality, can detect heart rhythms suggestive of atrial fibrillation (AFib). By continuously monitoring heart rhythms, the feature provides Galaxy Watch users with real-time notifications about potential AFib activity, empowering them to take proactive steps in managing their cardiovascular health.
Since its launch in 2020, the Samsung Health Monitor app has witnessed remarkable growth, reaching 74 markets worldwide. With over 15 million Galaxy Watch users already utilizing the app to track their ECG readings, it has become an invaluable tool for monitoring and recording heart rhythm, enabling users to gain a better understanding of their heart health.
As the IHRN feature expands its reach, it holds the potential to improve heart health awareness and contribute to the early detection and prevention of cardiovascular conditions. By leveraging technology, individuals can now actively monitor and manage their heart health, leading to healthier lifestyles.
Photo: SAMSUNG
About Author
+ There are no comments
Add yours